Annual Current Liabilities
$27.27 M
-$5.63 M-17.12%
December 31, 2023
Summary
- As of February 7, 2025, BTAI annual total current liabilities is $27.27 million, with the most recent change of -$5.63 million (-17.12%) on December 31, 2023.
- During the last 3 years, BTAI annual current liabilities has risen by +$15.43 million (+130.26%).
- BTAI annual current liabilities is now -17.12% below its all-time high of $32.90 million, reached on December 31, 2022.
Performance
BTAI Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$25.56 M
-$1.73 M-6.34%
September 30, 2024
Summary
- As of February 7, 2025, BTAI quarterly total current liabilities is $25.56 million, with the most recent change of -$1.73 million (-6.34%) on September 30, 2024.
- Over the past year, BTAI quarterly current liabilities has dropped by -$1.71 million (-6.27%).
- BTAI quarterly current liabilities is now -35.15% below its all-time high of $39.41 million, reached on September 30, 2023.
Performance
BTAI Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
BTAI Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.1% | -6.3% |
| 3 y3 years | +130.3% | +75.1% |
| 5 y5 years | +485.1% | +211.4% |
BTAI Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.1% | +63.6% | -35.1% | +59.8% |
| 5 y | 5-year | -17.1% | +222.0% | -35.1% | +201.8% |
| alltime | all time | -17.1% | +8137.8% | -35.1% | +1740.0% |
BioXcel Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $25.56 M(-6.3%) |
| Jun 2024 | - | $27.29 M(-13.3%) |
| Mar 2024 | - | $31.48 M(+15.5%) |
| Dec 2023 | $27.27 M(-17.1%) | $27.27 M(-30.8%) |
| Sep 2023 | - | $39.41 M(+13.4%) |
| Jun 2023 | - | $34.74 M(+20.8%) |
| Mar 2023 | - | $28.76 M(-12.6%) |
| Dec 2022 | $32.90 M(+97.4%) | $32.90 M(+40.7%) |
| Sep 2022 | - | $23.38 M(+16.9%) |
| Jun 2022 | - | $20.00 M(+25.0%) |
| Mar 2022 | - | $16.00 M(-4.0%) |
| Dec 2021 | $16.67 M(+40.7%) | $16.67 M(+14.2%) |
| Sep 2021 | - | $14.60 M(+17.3%) |
| Jun 2021 | - | $12.44 M(+0.9%) |
| Mar 2021 | - | $12.32 M(+4.1%) |
| Dec 2020 | $11.84 M | $11.84 M(-27.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $16.34 M(+1.1%) |
| Jun 2020 | - | $16.16 M(+31.8%) |
| Mar 2020 | - | $12.27 M(+44.8%) |
| Dec 2019 | $8.47 M(+81.7%) | $8.47 M(+3.2%) |
| Sep 2019 | - | $8.21 M(+2.5%) |
| Jun 2019 | - | $8.01 M(+17.7%) |
| Mar 2019 | - | $6.81 M(+46.1%) |
| Dec 2018 | $4.66 M(+99.4%) | $4.66 M(+128.1%) |
| Sep 2018 | - | $2.04 M(+47.1%) |
| Jun 2018 | - | $1.39 M(-67.0%) |
| Mar 2018 | - | $4.21 M(+80.4%) |
| Dec 2017 | $2.34 M(+606.0%) | $2.34 M |
| Dec 2016 | $331.00 K(-89.7%) | - |
| Jul 2016 | $3.22 M(+2.7%) | - |
| Jul 2015 | $3.14 M(-13.8%) | - |
| Jul 2014 | $3.64 M | - |
FAQ
- What is BioXcel Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for BioXcel Therapeutics?
- What is BioXcel Therapeutics annual current liabilities year-on-year change?
- What is BioXcel Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for BioXcel Therapeutics?
- What is BioXcel Therapeutics quarterly current liabilities year-on-year change?
What is BioXcel Therapeutics annual total current liabilities?
The current annual current liabilities of BTAI is $27.27 M
What is the all time high annual current liabilities for BioXcel Therapeutics?
BioXcel Therapeutics all-time high annual total current liabilities is $32.90 M
What is BioXcel Therapeutics annual current liabilities year-on-year change?
Over the past year, BTAI annual total current liabilities has changed by -$5.63 M (-17.12%)
What is BioXcel Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of BTAI is $25.56 M
What is the all time high quarterly current liabilities for BioXcel Therapeutics?
BioXcel Therapeutics all-time high quarterly total current liabilities is $39.41 M
What is BioXcel Therapeutics quarterly current liabilities year-on-year change?
Over the past year, BTAI quarterly total current liabilities has changed by -$1.71 M (-6.27%)